SINGAPORE — GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into GenScript’s state-of-the-art gene and protein production facility, particularly highlighting the company’s advancements in AI-driven gene […]
Vienna, Austria – Lexogen, a leading company in transcriptomics and Next-Generation Sequencing (NGS) announces the release of RiboCop rRNA Depletion for Plants, a solution that efficiently removes unwanted ribosomal RNA (rRNA) from various plant samples, including roots, seeds, and leaves from different plant species. RiboCop for Plants integrates seamlessly into end-to-end RNA-Seq workflows, enabling researchers to understand plant […]
Program will support faster insights for large-scale studies and drug development SEATTLE – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products. By combining powerful automation with the […]
Stockholm, Sweden – Renowned genomics pioneer, Bob Kain, has joined Single Technologies as an advisor to support the commercialization of their 3-D DNA sequencing system. Kain is perhaps most famous for his work at Illumina from 1999 to 2014. During this time, he not only helped the company grow from a 30-employee start-up into a […]
Devyser Diagnostics AB announces today it has entered into a co-marketing agreement with Hamilton Bonaduz AG, a leading global manufacturer of laboratory automation technology. The partnership enables Devyser to collaboratively market Hamilton liquid handling technologies, and to facilitate the automation of library preparation of Devyser NGS kits. This enables labs to benefit from a combined […]
OpenCRISPR-1 is publicly available and free to license for ethical research and commercial use BERKELEY, Calif.–Profluent, the AI-first protein design company, today debuted the OpenCRISPRTM initiative, releasing the world’s first open-source, AI-generated gene editor. With this launch, Profluent demonstrates the first successful precision editing of the human genome with customizable gene editors designed from scratch […]
The laboratory has state-of-the-art technology to support medical research of clinical labs and healthcare institutions, improving precision diagnoses and treatments. The agricultural sector can also benefit. São Paulo, Brazil – Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life […]
Takara Bio has released PrimeCap T7 RNA Polymerase (low dsRNA) (hereafter referred to as PrimeCap T7 RNA Polymerase), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development, in March 2024. mRNA vaccines have been deployed effectively as a defense against the coronavirus, with ongoing research extending beyond infectious disease prevention to encompass […]
cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development; Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine SAN DIEGO — TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility. […]
SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform. Going forward, the company will increasingly concentrate its efforts on expanding the adoption of Gibson SOLA for both DNA and […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
